NM_001879.6:c.1909+188G>C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001879.6(MASP1):​c.1909+188G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.028 in 152,260 control chromosomes in the GnomAD database, including 90 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.028 ( 90 hom., cov: 31)

Consequence

MASP1
NM_001879.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0110

Publications

0 publications found
Variant links:
Genes affected
MASP1 (HGNC:6901): (MBL associated serine protease 1) This gene encodes a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response. The encoded protein is synthesized as a zymogen and is activated when it complexes with the pathogen recognition molecules of lectin pathway, the mannose-binding lectin and the ficolins. This protein is not directly involved in complement activation but may play a role as an amplifier of complement activation by cleaving complement C2 or by activating another complement serine protease, MASP-2. The encoded protein is also able to cleave fibrinogen and factor XIII and may may be involved in coagulation. A splice variant of this gene which lacks the serine protease domain functions as an inhibitor of the complement pathway. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
MASP1 Gene-Disease associations (from GenCC):
  • 3MC syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • 3MC syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 3-187220847-C-G is Benign according to our data. Variant chr3-187220847-C-G is described in ClinVar as Benign. ClinVar VariationId is 1224913.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0544 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001879.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MASP1
NM_001879.6
MANE Plus Clinical
c.1909+188G>C
intron
N/ANP_001870.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MASP1
ENST00000337774.10
TSL:1 MANE Plus Clinical
c.1909+188G>C
intron
N/AENSP00000336792.5P48740-1

Frequencies

GnomAD3 genomes
AF:
0.0279
AC:
4246
AN:
152142
Hom.:
87
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0564
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.0163
Gnomad ASJ
AF:
0.0343
Gnomad EAS
AF:
0.00463
Gnomad SAS
AF:
0.0294
Gnomad FIN
AF:
0.0246
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0145
Gnomad OTH
AF:
0.0344
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0280
AC:
4262
AN:
152260
Hom.:
90
Cov.:
31
AF XY:
0.0279
AC XY:
2078
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0563
AC:
2338
AN:
41544
American (AMR)
AF:
0.0163
AC:
249
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0343
AC:
119
AN:
3466
East Asian (EAS)
AF:
0.00464
AC:
24
AN:
5176
South Asian (SAS)
AF:
0.0296
AC:
143
AN:
4824
European-Finnish (FIN)
AF:
0.0246
AC:
261
AN:
10610
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0145
AC:
988
AN:
68026
Other (OTH)
AF:
0.0398
AC:
84
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
203
406
609
812
1015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0224
Hom.:
4
Bravo
AF:
0.0287
Asia WGS
AF:
0.0330
AC:
118
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.95
DANN
Benign
0.32
PhyloP100
0.011
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9864944; hg19: chr3-186938635; API